Moderna (MRNA) Inventory (2020 - 2025)
Historic Inventory for Moderna (MRNA) over the last 6 years, with Q3 2025 value amounting to $332.0 million.
- Moderna's Inventory fell 1941.75% to $332.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $332.0 million, marking a year-over-year decrease of 1941.75%. This contributed to the annual value of $117.0 million for FY2024, which is 4207.92% down from last year.
- Per Moderna's latest filing, its Inventory stood at $332.0 million for Q3 2025, which was down 1941.75% from $240.0 million recorded in Q2 2025.
- Moderna's 5-year Inventory high stood at $2.1 billion for Q3 2022, and its period low was $117.0 million during Q4 2024.
- In the last 5 years, Moderna's Inventory had a median value of $494.0 million in 2021 and averaged $762.7 million.
- In the last 5 years, Moderna's Inventory surged by 296595.74% in 2021 and then tumbled by 7871.44% in 2023.
- Over the past 5 years, Moderna's Inventory (Quarter) stood at $1.4 billion in 2021, then tumbled by 34.14% to $949.0 million in 2022, then plummeted by 78.71% to $202.0 million in 2023, then crashed by 42.08% to $117.0 million in 2024, then soared by 183.76% to $332.0 million in 2025.
- Its Inventory was $332.0 million in Q3 2025, compared to $240.0 million in Q2 2025 and $128.0 million in Q1 2025.